Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Verapamil + magnesium sulfate is a drug combination that has important clinical implications due to their pharmacological interactions. This combination consists of verapamil, a calcium channel blocker, and magnesium sulfate, an electrolyte supplement with multiple therapeutic uses. ## Pharmacological Properties Verapamil is a calcium channel blocker primarily used for treating hypertension, angina, and certain cardiac arrhythmias. It works by relaxing blood vessels and affecting the heart's electrical activity[8]. Specifically, verapamil dilates coronary arteries and arterioles in both normal and ischemic regions, inhibits coronary artery spasm, and reduces myocardial oxygen demand[8]. Magnesium sulfate is used for various conditions including convulsions during pregnancy (pre-eclampsia and eclampsia), nephritis in children, magnesium deficiency, and tetany[5]. It also has applications in treating constipation and as a myometrial relaxant[5]. ## Interaction Effects When used together, verapamil and magnesium sulfate demonstrate several significant interactions: 1. **Cardiac Effects**: Magnesium sulfate can potentiate the cardiac depression caused by verapamil in a dose-dependent manner[1]. This interaction could potentially increase the risk of arrhythmias[2][5]. 2. **Protein Binding**: Magnesium sulfate increases the protein binding of verapamil hydrochloride, forming a stable 1:1 complex. This increased binding may lead to: - Decreased hepatic and renal clearance of verapamil - Increased half-life of verapamil - Potentially more pronounced adverse effects[3] 3. **Blood Pressure Effects**: Both medications can lower blood pressure. When taken together, they might cause blood pressure to drop too low in some patients[9]. ## Therapeutic Applications Despite these interactions, the combination has been studied for potential therapeutic benefits in certain conditions: 1. **Bipolar Disorder**: Early research suggests that taking magnesium by mouth along with verapamil reduces manic symptoms better than verapamil alone in people with bipolar disorder[6]. 2. **Supraventricular Arrhythmias**: Both drugs individually have effects on cardiac arrhythmias. A study comparing magnesium sulfate to verapamil for treating supraventricular arrhythmias found that magnesium was at least as effective as verapamil for conversion to sinus rhythm, with a more rapid action and fewer side effects[7]. ## Clinical Considerations Healthcare providers should exercise caution when administering these medications concurrently due to: 1. **Increased Risk of Adverse Effects**: The combination may enhance the cardiac depressant effects of both drugs[1]. 2. **Pharmacokinetic Changes**: The formation of verapamil-magnesium complexes alters the pharmacokinetics of verapamil, potentially affecting its clearance and half-life[3]. 3. **Special Populations**: Particular caution is needed in patients with renal impairment, as approximately 70% of verapamil is excreted as metabolites in the urine, and impaired kidney function could lead to accumulation of both drugs[8]. When prescribing this combination, careful monitoring of cardiac function and blood pressure is essential to prevent potential adverse effects from their interaction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Verapamil and magnesium sulfate.